Something better? Competitors can only offer new small iterations to upcoming valves (see Sapien X4).
The only threat would be a one piece non-bioprosphetic (spelling?) valve. I guess everybody, including us, is working on that. But at this point in time, Sapien X4 appears to be our future main competitor in 2027-28....
Further Update on Edwards, page-174
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.00 |
Change
-0.400(2.06%) |
Mkt cap ! $365.2M | |||
| Open | High | Low | Value | Volume |
| $19.35 | $19.35 | $18.49 | $184.4K | 9.773K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $18.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.40 | 99 | 1 |
View Market Depth
| Last trade - 15.06pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.92 |
Change
-0.400 ( 0.84 %) |
||||
| Open | High | Low | Volume | ||
| $19.26 | $19.27 | $18.52 | 328 | ||
| Last updated 15.06pm 24/05/2024 ? | |||||
| AVR (ASX) Chart |